AAAAAA

   
Results: 1-7 |
Results: 7
PHENOTYPE AND GENOTYPE OF ADVANCED PREMALIGNANT HEAD AND NECK LESIONSAFTER CHEMOPREVENTIVE THERAPY
Authors: MAO L EINAGGAR AK PAPADIMITRAKOPOULOU V SHIN DM SHIN HC FAN YH ZHOU X CLAYMAN G LEE JJ LEE JS HITTELMAN WN LIPPMAN SM HONG WK
Citation: L. Mao et al., PHENOTYPE AND GENOTYPE OF ADVANCED PREMALIGNANT HEAD AND NECK LESIONSAFTER CHEMOPREVENTIVE THERAPY, Journal of the National Cancer Institute, 90(20), 1998, pp. 1545-1551
CHEMOPREVENTION IN HEAD AND NECK-CANCER - BASIC SCIENCE AND CLINICAL-APPLICATION
Authors: GEYER C PAPADIMITRAKOPOULOU V HONG WK
Citation: C. Geyer et al., CHEMOPREVENTION IN HEAD AND NECK-CANCER - BASIC SCIENCE AND CLINICAL-APPLICATION, Seminars in radiation oncology, 8(4), 1998, pp. 292-301
PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: SHIN DM GLISSON BS KHURI FR GINSBERG L PAPADIMITRAKOPOULOU V LEE JJ LAWHORN K GILLENWATER AM ANG KK CLAYMAN GL CALLENDER DL HONG WK LIPPMAN SM
Citation: Dm. Shin et al., PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Journal of clinical oncology, 16(4), 1998, pp. 1325-1330
PRIMARY PAROTID LYMPHOMA - THE EFFECT OF INTERNATIONAL PROGNOSTIC INDEX ON OUTCOME
Authors: SARRIS AH PAPADIMITRAKOPOULOU V DIMOPOULOS MA SMITH T PUGH W HA CS MCLAUGHLIN P CALLENDER D COX J CABANILLAS F
Citation: Ah. Sarris et al., PRIMARY PAROTID LYMPHOMA - THE EFFECT OF INTERNATIONAL PROGNOSTIC INDEX ON OUTCOME, Leukemia & lymphoma, 26(1-2), 1997, pp. 49-56
FREQUENT INACTIVATION OF P16(INK4A) IN ORAL PREMALIGNANT LESIONS
Authors: PAPADIMITRAKOPOULOU V IZZO J LIPPMAN SM LEE JS FAN YH CLAYMAN G RO JY HITTELMAN WN LOTAN R HONG WK MAO L
Citation: V. Papadimitrakopoulou et al., FREQUENT INACTIVATION OF P16(INK4A) IN ORAL PREMALIGNANT LESIONS, Oncogene, 14(15), 1997, pp. 1799-1803
DPC4, A CANDIDATE TUMOR-SUPPRESSOR GENE, IS ALTERED INFREQUENTLY IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: KIM SK FAN YH PAPADIMITRAKOPOULOU V CLAYMAN G HITTELMAN WN HONG WK LOTAN R MAO L
Citation: Sk. Kim et al., DPC4, A CANDIDATE TUMOR-SUPPRESSOR GENE, IS ALTERED INFREQUENTLY IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Cancer research, 56(11), 1996, pp. 2519-2521
COMBINED EPIRUBICIN, EPIRUBICIN, 5-FLUOROURACIL AND FOLINIC ACID WITHALLOPURINOL PROTECTION FOR 2ND-LINE TREATMENT OF ADVANCED GASTRIC-CANCER - A PILOT-STUDY
Authors: TSAVARIS N MYLONAKIS N BACOYIANNIS C PAPASTRATIS G KATSIKAS M PAPADIMITRAKOPOULOU V MACHERAS A STAMELOU A KOSMIDIS P
Citation: N. Tsavaris et al., COMBINED EPIRUBICIN, EPIRUBICIN, 5-FLUOROURACIL AND FOLINIC ACID WITHALLOPURINOL PROTECTION FOR 2ND-LINE TREATMENT OF ADVANCED GASTRIC-CANCER - A PILOT-STUDY, Onkologie, 18(4), 1995, pp. 346-350
Risultati: 1-7 |